Actively Recruiting
Plant-Protein Dominant Tube Feed Study
Led by Nutricia UK Ltd · Updated on 2026-02-20
110
Participants Needed
1
Research Sites
60 weeks
Total Duration
On this page
Sponsors
N
Nutricia UK Ltd
Lead Sponsor
U
University Hospitals Coventry and Warwickshire NHS Trust
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aims to determine whether a reformulated plant-protein dominant protein blend in four existing enteral tube feeds is as effective as animal-protein dominant formulations in patients who are tube fed at home. This is an exploratory randomised, controlled, trial with a 3-day baseline period. Adult home tube feeding patients will be randomised to receive either a plant-protein dominant formulation or a control product (an animal-protein dominant formulation) for a 3-month intervention period followed by a 6-month and 12-month follow-up. The outcomes include gastrointestinal tolerance, compliance, acceptability, anthropometry, nutrient intake, and physical function
CONDITIONS
Official Title
Plant-Protein Dominant Tube Feed Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female aged 16 years or older
- Using or requiring an enteral tube feed at home as part of nutritional management
- Expected to receive at least 500ml (500 kcal) per day from one of the study products
You will not qualify if you...
- Receiving nutrition through parenteral nutrition
- Major liver dysfunction such as decompensated liver disease
- Major kidney dysfunction requiring filtration or stage 4/5 chronic kidney disease
- Currently receiving inpatient care
- Known pregnancy or breastfeeding
- Participation in other clinical intervention studies within 1 month
- Allergy to any ingredients in the study products
- Investigator concerns about ability or willingness to comply with study requirements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Nutricia Ltd
Trowbridge, Wiltshire, United Kingdom, BA14 0XQ
Actively Recruiting
Research Team
S
Sophie Bell
CONTACT
E
Ellen Taylor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here